NanoSyrinx

NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for cell and gene editing, is creating a novel system for the direct cytosolic delivery of therapeutic proteins and peptides. We are leveraging a synthetic biology approach to develop a completely new method for targeted intracellular delivery of therapeutic proteins and peptides, enhancing efficacy, safety, and cost-efficiency.